Tag: AstraZeneca PLC

AstraZeneca’s COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca’s trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

AstraZeneca stock dives 9% after heart drug trial misses target

Drugmakers race to find a place in the next wave of obesity drugs

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed